The WACC of Poseida Therapeutics, Inc. (PSTX) is 8.2%.
Range | Selected | |
Cost of equity | 6.90% - 9.60% | 8.25% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 7.00% - 12.70% | 9.85% |
WACC | 6.8% - 9.6% | 8.2% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.66 | 0.85 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.90% | 9.60% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 0.06 | 0.06 |
Cost of debt | 7.00% | 12.70% |
After-tax WACC | 6.8% | 9.6% |
Selected WACC | 8.2% | |